DE69227306T2 - Behandlung von zellgewebsentzündung mit retinoide - Google Patents

Behandlung von zellgewebsentzündung mit retinoide

Info

Publication number
DE69227306T2
DE69227306T2 DE69227306T DE69227306T DE69227306T2 DE 69227306 T2 DE69227306 T2 DE 69227306T2 DE 69227306 T DE69227306 T DE 69227306T DE 69227306 T DE69227306 T DE 69227306T DE 69227306 T2 DE69227306 T2 DE 69227306T2
Authority
DE
Germany
Prior art keywords
retinoids
ignition
tissue
treatment
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69227306T
Other languages
English (en)
Other versions
DE69227306D1 (de
Inventor
Albert M Kligman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69227306D1 publication Critical patent/DE69227306D1/de
Publication of DE69227306T2 publication Critical patent/DE69227306T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69227306T 1991-02-27 1992-02-26 Behandlung von zellgewebsentzündung mit retinoide Expired - Lifetime DE69227306T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/661,753 US5051449A (en) 1991-02-27 1991-02-27 Treatment of cellulite with retinoids
PCT/US1992/001541 WO1992015293A1 (en) 1991-02-27 1992-02-26 Treatment of cellulite with retinoids

Publications (2)

Publication Number Publication Date
DE69227306D1 DE69227306D1 (de) 1998-11-19
DE69227306T2 true DE69227306T2 (de) 1999-06-02

Family

ID=24654977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227306T Expired - Lifetime DE69227306T2 (de) 1991-02-27 1992-02-26 Behandlung von zellgewebsentzündung mit retinoide

Country Status (17)

Country Link
US (1) US5051449A (de)
EP (1) EP0573601B1 (de)
JP (1) JP2893483B2 (de)
KR (1) KR100224284B1 (de)
AT (1) ATE172113T1 (de)
AU (1) AU666303B2 (de)
CA (1) CA2104452C (de)
DE (1) DE69227306T2 (de)
DK (1) DK0573601T3 (de)
ES (1) ES2124725T3 (de)
FI (1) FI103950B (de)
HU (1) HU218914B (de)
IE (1) IE920624A1 (de)
NO (1) NO304727B1 (de)
NZ (1) NZ241757A (de)
SG (1) SG69981A1 (de)
WO (1) WO1992015293A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
US5521221A (en) * 1991-04-09 1996-05-28 Sloan-Kettering Institute For Cancer Research Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol
JP2765354B2 (ja) * 1992-03-09 1998-06-11 住友電装株式会社 接続具における電線の敷線方法
US5587396A (en) * 1994-08-26 1996-12-24 Mary Kay Inc. Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5529769A (en) 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
JPH11513683A (ja) * 1995-10-18 1999-11-24 マリー カイ インコーポレーテッド 局部的に適用された構造上のセリュライト処理
DE69531559D1 (de) * 1995-10-18 2003-09-25 Mary Kay Inc Topisch angewandte strukturelle behandlungen der zellulitis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
EP1720605A4 (de) * 2003-06-23 2007-10-24 Transpharma Medical Ltd Transdermales abgabesystem für kosmetische mittel
FR2863492B1 (fr) * 2003-12-10 2007-08-24 Oreal Utilisation des modulateurs d'aquaglyceroporines comme amincissant
WO2007016050A1 (en) * 2005-07-28 2007-02-08 Global Cosmeceutical Innovations, Llc Composition and method for treating cellulite
EP2056782A1 (de) * 2006-08-30 2009-05-13 Merck Patent GmbH Verwendung von chromen-4-on-derivaten
ATE441408T1 (de) 2007-03-20 2009-09-15 Johnson & Johnson Consumer Fr Zusammensetzung enthältend retinoid und beta- aminoisobuttersäurederivate
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
DE102010054149A1 (de) 2010-12-10 2012-06-14 Merck Patent Gmbh 2-Pyrone
EP3368009A1 (de) 2015-10-30 2018-09-05 Patagonia Pharmaceuticals, LLC Isotretinoinformulierungen sowie verwendungen und verfahren dafür

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4288633A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
MX9201084A (es) * 1991-04-15 1992-12-21 Bristol Myers Squibb Co Hiper pigmentacion de la piel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut

Also Published As

Publication number Publication date
NO932949D0 (no) 1993-08-19
EP0573601A1 (de) 1993-12-15
CA2104452A1 (en) 1992-08-28
US5051449A (en) 1991-09-24
AU666303B2 (en) 1996-02-08
ATE172113T1 (de) 1998-10-15
HU9302437D0 (en) 1993-11-29
DK0573601T3 (da) 1999-06-23
NO932949L (no) 1993-08-19
ES2124725T3 (es) 1999-02-16
FI103950B1 (fi) 1999-10-29
HU218914B (hu) 2000-12-28
JP2893483B2 (ja) 1999-05-24
FI933736A0 (fi) 1993-08-25
FI103950B (fi) 1999-10-29
KR100224284B1 (ko) 1999-10-15
CA2104452C (en) 2002-07-16
WO1992015293A1 (en) 1992-09-17
AU1644892A (en) 1992-10-06
EP0573601B1 (de) 1998-10-14
SG69981A1 (en) 2000-01-25
DE69227306D1 (de) 1998-11-19
EP0573601A4 (de) 1994-01-12
NO304727B1 (no) 1999-02-08
NZ241757A (en) 1994-04-27
IE920624A1 (en) 1992-09-09
KR930702992A (ko) 1993-11-29
HUT65651A (en) 1994-07-28
JPH06507395A (ja) 1994-08-25
FI933736A (fi) 1993-08-25

Similar Documents

Publication Publication Date Title
DE69227306D1 (de) Behandlung von zellgewebsentzündung mit retinoide
DE69029804T2 (de) VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
DE69210515T2 (de) Kosmetisches Mittel
ES2058517T3 (es) Composicion cosmetica.
NO973900L (no) Nitrogenoksyd syntase inhibitor
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
ATE209483T1 (de) Behandlung von multipler sklerose
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
EP0415458B1 (de) Verwendung von Retinoiden zur Verhinderung und Verkleinerung von Dehnungsstreifen
EA199800194A1 (ru) Способ косметического лечения и предупреждения появления признаков старения кожи
DE69018570T2 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
DE68912227T2 (de) Behandlung von Periodontoklasie mit Retinsäure.
GB2302281A (en) Control for psoriasis
TH15130EX (th) ส่วนประกอบของเครื่องสำอางที่ใช้กับผิวหนังที่ก่อ ให้เกิดการระคายเคืองต่ำสำหรับใช้เฉพาะแห่งเป็น ประจำทุกวัน, การนำไปใช้และการผลิต
RU94037474A (ru) Косметический крем
GR890100035A (en) Method for preparation of a means that contains salicyloxyd against scaling sick

Legal Events

Date Code Title Description
8364 No opposition during term of opposition